Media

partnering

Trianni, Inc. and MacroGenics, Inc. Announce License Agreement

Read Full Release San Francisco, CA and Rockville, MD USA, Dec 6, 2018 – Trianni, Inc. (“TRIANNI”) and MacroGenics, Inc. […]

Continue reading

Trianni, Inc. and Simon Fraser University Announce 
Licensing Agreement for The Trianni Mouse™

Full Release San Francisco, CA, USA, September 18, 2018 – Trianni, Inc. (“TRIANNI”) and Simon Fraser University (“SFU”) announced today […]

Continue reading

Gilead Enters Licensing Agreement With Trianni for Use of Trianni Transgenic Human Monoclonal Antibody Discovery Platform

FOSTER CITY, Calif. & SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Sep. 4, 2018– Gilead Sciences, Inc. (NASDAQ: GILD) and Trianni, Inc. (“TRIANNI”) […]

Continue reading

Trianni, Inc. Signs Licensing Agreement with Straterx, Inc.

San Francisco, CA, USA, June 12, 2018 – Trianni, Inc. (“TRIANNI”) announced today that it has entered into a license […]

Continue reading

Mouse Powered Progress: Producing Humanized Monoclonal Antibodies With Transgenic Mice

Antibodies are a critical feature of the human adaptive immune response. New immunotherapies require the production of selective and non-autoimmunogenic […]

Continue reading

Trianni, Inc. and NovaRock Biotherapeutics, Ltd. Announce Licensing Agreement

San Francisco, CA, USA, March 28, 2018 – Trianni, Inc. (“TRIANNI”) and NovaRock Biotherapeutics, Ltd. (“NOVAROCK”) jointly announced today that […]

Continue reading

ENTHERA and TRIANNI Announce Licensing Agreement

San Francisco, CA, USA and Milano, Italy, March 22, 2018 – Trianni, Inc. (“TRIANNI”) and Enthera, S.r.l. (“ENTHERA”) jointly announced […]

Continue reading

TRIANNI Supports Immunology Program in Developing Regions

San Francisco, CA, USA., Feb 7, 2018 –Trianni, Inc. (“TRIANNI”) announced their support of the Education Committee of International Union […]

Continue reading

TRIANNI sponsors The Werner Müller Award for Excellence in Immunology

San Francisco, CA, USA. and Berlin, Germany, December 6, 2017 –Trianni, Inc. (“TRIANNI”) announced that it will sponsor the Werner […]

Continue reading

Trianni and Juno Therapeutics Sign Licensing Agreement for Use of Trianni Transgenic Mouse Platform

San Francisco, CA, USA, October 18, 2017– Trianni, Inc. (“TRIANNI”).  today announced that Juno Therapeutics (NASDAQ: JUNO) has entered into […]

Continue reading